Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6AEE

Crystal structure of the four Ig-like domains of LILRB1 complexed with HLA-G

6AEE の概要
エントリーDOI10.2210/pdb6aee/pdb
分子名称HLA class I histocompatibility antigen, alpha chain G, Beta-2-microglobulin, 9 Mer Peptide (RL9) From Histone H2A.x, ... (4 entities in total)
機能のキーワードleukocyte immunoglobulin-like receptor; immunotherapy, immune system
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数8
化学式量合計178434.97
構造登録者
Wang, Q.,Song, H.,Qi, J.,Gao, G.F. (登録日: 2018-08-04, 公開日: 2019-07-31, 最終更新日: 2024-10-16)
主引用文献Wang, Q.,Song, H.,Cheng, H.,Qi, J.,Nam, G.,Tan, S.,Wang, J.,Fang, M.,Shi, Y.,Tian, Z.,Cao, X.,An, Z.,Yan, J.,Gao, G.F.
Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex.
Cell. Mol. Immunol., 2019
Cited by
PubMed Abstract: Leukocyte immunoglobulin (Ig)-like receptors (LILRs), also known as CD85 and immunoglobulin-like transcripts (ILTs), play pivotal roles in regulating immune responses. These receptors define an immune checkpoint that immune therapy can target. Through cis or trans interactions with human leukocyte antigen (HLA)-G, the two most abundantly expressed inhibitory LILRs, LILRB1, and LILRB2 (LILRB1/2, also known as CD85j/d and ILT2/4), are involved in immunotolerance in pregnancy and transplantation, autoimmune diseases, and immune evasion by tumors. Although the discrete domains of LILRB1/2 are clear, the assembly mode of the four extracellular Ig-like domains (D1, D2, D3, and D4) remains unknown. Previous data indicate that D1D2 is responsible for binding to HLA class I (HLA-I), but the roles of D3D4 are still unclear. Here, we determined the crystal structure of the four Ig-like domain LILRB2 and four-domain LILRB1 in complex with HLA-G1. The angles between adjacent domains and the staggered assembly of the four domains suggest limited flexibility and limited plasticity of the receptors during ligand binding. The complex structure of four-domain LILRB1 and HLA-G1 supports the model that D1D2 is responsible for HLA-I binding, while D3D4 acts as a scaffold. Accordingly, cis and trans binding models for HLA-I binding to LILRB1/2 are proposed. The geometries of LILRB1/2 in complex with dimeric and monomeric HLA-G1 suggest the accessibility of the dimeric receptor, which in turn, transduces more inhibitory signals. The assembly of LILRB1/2 and its binding to HLA-G1 could aid in the design of immune regulators and benefit immune interference.
PubMed: 31273318
DOI: 10.1038/s41423-019-0258-5
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.303 Å)
構造検証レポート
Validation report summary of 6aee
検証レポート(詳細版)ダウンロードをダウンロード

238895

件を2025-07-16に公開中

PDB statisticsPDBj update infoContact PDBjnumon